Certara (NASDAQ:CERT) Hits New 12-Month Low – Should You Sell?

Certara, Inc. (NASDAQ:CERT)’s share price hit a new 52-week low during trading on Friday . The company traded as low as $9.96 and last traded at $10.02, with a volume of 102445 shares trading hands. The stock had previously closed at $10.53.

Analyst Upgrades and Downgrades

A number of analysts recently commented on CERT shares. Robert W. Baird decreased their target price on Certara from $18.00 to $13.00 and set a “neutral” rating for the company in a research report on Tuesday, November 5th. Barclays decreased their target price on Certara from $14.00 to $12.00 and set an “equal weight” rating for the company in a research report on Thursday, November 7th. Finally, UBS Group raised Certara from a “neutral” rating to a “buy” rating and set a $16.00 target price for the company in a research report on Friday, September 27th. Six analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $15.92.

Certara Price Performance

The firm has a market cap of $1.61 billion, a price-to-earnings ratio of -52.65, a P/E/G ratio of 5.46 and a beta of 1.51. The company has a debt-to-equity ratio of 0.28, a quick ratio of 2.86 and a current ratio of 2.86. The business has a 50 day simple moving average of $10.93 and a 200-day simple moving average of $13.54.

Certara (NASDAQ:CERT) last released its quarterly earnings results on Wednesday, November 6th. The company reported $0.13 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.11 by $0.02. The business had revenue of $94.80 million during the quarter, compared to the consensus estimate of $95.51 million. Certara had a positive return on equity of 3.43% and a negative net margin of 8.34%. The company’s quarterly revenue was up 10.7% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.06 EPS. Equities research analysts expect that Certara, Inc. will post 0.28 earnings per share for the current year.

Insider Transactions at Certara

In other news, insider Patrick F. Smith sold 5,409 shares of the business’s stock in a transaction that occurred on Monday, October 7th. The stock was sold at an average price of $11.03, for a total value of $59,661.27. Following the transaction, the insider now owns 50,091 shares in the company, valued at $552,503.73. The trade was a 9.75 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Leif E. Pedersen sold 51,224 shares of the business’s stock in a transaction that occurred on Monday, September 9th. The stock was sold at an average price of $11.29, for a total value of $578,318.96. Following the completion of the transaction, the insider now owns 99,704 shares in the company, valued at $1,125,658.16. The trade was a 33.94 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 2.39% of the company’s stock.

Hedge Funds Weigh In On Certara

Several institutional investors have recently bought and sold shares of the company. Wasatch Advisors LP lifted its stake in Certara by 22.4% in the third quarter. Wasatch Advisors LP now owns 9,015,941 shares of the company’s stock valued at $105,577,000 after purchasing an additional 1,651,076 shares during the last quarter. Geneva Capital Management LLC lifted its stake in Certara by 0.7% in the third quarter. Geneva Capital Management LLC now owns 5,510,209 shares of the company’s stock valued at $64,525,000 after purchasing an additional 37,392 shares during the last quarter. Clearbridge Investments LLC lifted its stake in Certara by 0.8% in the first quarter. Clearbridge Investments LLC now owns 4,173,195 shares of the company’s stock valued at $74,617,000 after purchasing an additional 32,846 shares during the last quarter. Massachusetts Financial Services Co. MA lifted its stake in Certara by 40.7% in the third quarter. Massachusetts Financial Services Co. MA now owns 3,901,898 shares of the company’s stock valued at $45,691,000 after purchasing an additional 1,128,006 shares during the last quarter. Finally, Dimensional Fund Advisors LP lifted its stake in Certara by 9.7% in the second quarter. Dimensional Fund Advisors LP now owns 3,079,023 shares of the company’s stock valued at $42,643,000 after purchasing an additional 273,095 shares during the last quarter. Hedge funds and other institutional investors own 73.96% of the company’s stock.

About Certara

Certara, Inc, together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solution used to predict both pharmacokinetics and pharmacodynamics.